Heart Test Laboratories, Inc. announced that it will receive $1,085,006 in funding on November 15, 2023. The company will issue convertible preferred shares, convertible corporate debt and undisclosed securities in the transaction. The company will issue securities pursuant to exemption provided under Regulation D. The company represents 3,125,000 shares of common stock issued to a noteholder to pay off $500,000 drawn from a note and 3,656,388 shares of common stock issued to a noteholder to pay off principal and interest under a loan agreement.